ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 1 مورد

Chronic graft-versus-host disease: Initial management

Chronic graft-versus-host disease: Initial management
This algorithm describes initial management of cGVHD. Refer to related UpToDate material for details of diagnosis, grading, symptom management, acceptable alternatives, and management of inadequate response or SR-cGVHD.

BSA: body surface area; cGVHD: chronic graft-versus-host disease; GI: gastrointestinal; NIH: National Institutes of Health; SR-cGVHD: steroid-refractory cGVHD.

* The cGVHD severity score is based on a modified NIH scoring system, which includes assessment of skin, mouth, eyes, GI tract, liver, lungs, joints/fascia, and genital tract. Scoring of severity at each involved site and determination of the overall severity score are discussed in related UpToDate material.

¶ Preferred topical treatments vary according to site(s) of involvement (eg, skin, oral mucosa, etc).

Δ Some experts favor systemic prednisone alone for severe cGVHD.

Graphic 146483 Version 1.0